{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:24:54Z","timestamp":1770276294833,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s11102-023-01307-6","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:49:40Z","timestamp":1679878180000},"page":"221-226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["IGF-1 is positively associated with BMI in patients with acromegaly"],"prefix":"10.1007","volume":"26","author":[{"given":"Anamil","family":"Khiyami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharini","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios A.","family":"Zenonos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1731-2927","authenticated-orcid":false,"given":"Pouneh K.","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"issue":"3","key":"1307_CR1","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/JOE-13-0477","volume":"220","author":"PK Fazeli","year":"2014","unstructured":"Fazeli PK, Klibanski A (2014) Determinants of GH resistance in malnutrition. J Endocrinol 220(3):R57-65","journal-title":"J Endocrinol"},{"issue":"3","key":"1307_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41574-019-0280-9","volume":"16","author":"JJ Kopchick","year":"2020","unstructured":"Kopchick JJ, Berryman DE, Puri V, Lee KY, Jorgensen JOL (2020) The effects of growth hormone on adipose tissue: old observations, new mechanisms. Nat Rev Endocrinol 16(3):135\u2013146","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1307_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/ncpendmet0427","volume":"3","author":"D LeRoith","year":"2007","unstructured":"LeRoith D, Yakar S (2007) Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 3(3):302\u2013310","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"5","key":"1307_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1530\/eje.1.02131","volume":"154","author":"HJ Schneider","year":"2006","unstructured":"Schneider HJ, Saller B, Klotsche J, M\u00e4rz W, Erwa W, Wittchen HU, Stalla GK (2006) Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur J Endocrinol 154(5):699\u2013706","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1307_CR5","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/sj.ijo.0803324","volume":"30","author":"IT Gram","year":"2006","unstructured":"Gram IT, Norat T, Rinaldi S, Dossus L, Lukanova A, T\u00e9hard B, Clavel-Chapelon F, van Gils CH, van Noord PA, Peeters PH, Bueno-de-Mesquita HB, Nagel G, Linseisen J, Lahmann PH, Boeing H, Palli D, Sacerdote C, Panico S, Tumino R, Sieri S, Dorronsoro M, Quir\u00f3s JR, Navarro CA, Barricarte A, Tormo MJ, Gonz\u00e1lez CA, Overvad K, Paaske Johnsen S, Olsen A, Tj\u00f8nneland A, Travis R, Allen N, Bingham S, Khaw KT, Stattin P, Trichopoulou A, Kalapothaki V, Psaltopoulou T, Casagrande C, Riboli E, Kaaks R (2006) Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Int J Obes (Lond) 30(11):1623\u20131631","journal-title":"Int J Obes (Lond)"},{"issue":"22","key":"1307_CR6","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1056\/NEJM198411293112203","volume":"311","author":"T Williams","year":"1984","unstructured":"Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA (1984) Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 311(22):1403\u20131407","journal-title":"N Engl J Med"},{"issue":"2","key":"1307_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1365-2265.1989.tb03733.x","volume":"30","author":"BA Bengtsson","year":"1989","unstructured":"Bengtsson BA, Brummer RJ, Ed\u00e9n S, Bosaeus I (1989) Body composition in acromegaly. Clin Endocrinol (Oxf) 30(2):121\u2013130","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1307_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00005792-199409000-00001","volume":"73","author":"S Ezzat","year":"1994","unstructured":"Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG (1994) Acromegaly. Clinical and biochemical features in 500 patients. Medicine (Baltimore) 73(5):233\u2013240","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1307_CR9","first-page":"381","volume":"78","author":"AJ O'Sullivan","year":"1994","unstructured":"O\u2019Sullivan AJ, Kelly JJ, Hoffman DM, Freund J, Ho KK (1994) Body composition and energy expenditure in acromegaly. J Clin Endocrinol Metab 78(2):381\u2013386","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1307_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2265.1989.tb01272.x","volume":"31","author":"BA Bengtsson","year":"1989","unstructured":"Bengtsson BA, Brummer RJ, Ed\u00e9n S, Bosaeus I, Lindstedt G (1989) Body composition in acromegaly: the effect of treatment. Clin Endocrinol (Oxf) 31(4):481\u2013490","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1307_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1530\/EJE-08-0449","volume":"159","author":"N Sucunza","year":"2008","unstructured":"Sucunza N, Barahona MJ, Resmini E, Fern\u00e1ndez-Real JM, Farrerons J, Lluch P, Puig T, W\u00e4gner AM, Ricart W, Webb SM (2008) Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females. Eur J Endocrinol 159(6):773\u2013779","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1307_CR12","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1210\/jc.2007-2780","volume":"93","author":"PU Freda","year":"2008","unstructured":"Freda PU, Shen W, Heymsfield SB, Reyes-Vidal CM, Geer EB, Bruce JN, Gallagher D (2008) Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J Clin Endocrinol Metab 93(6):2334\u20132343","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1307_CR13","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1210\/jc.2009-0026","volume":"94","author":"PU Freda","year":"2009","unstructured":"Freda PU, Shen W, Reyes-Vidal CM, Geer EB, Arias-Mendoza F, Gallagher D, Heymsfield SB (2009) Skeletal muscle mass in acromegaly assessed by magnetic resonance imaging and dual-photon x-ray absorptiometry. J Clin Endocrinol Metab 94(8):2880\u20132886","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1307_CR14","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1210\/jc.2014-2259","volume":"99","author":"C Reyes-Vidal","year":"2014","unstructured":"Reyes-Vidal C, Fernandez JC, Bruce JN, Crisman C, Conwell IM, Kostadinov J, Geer EB, Post KD, Freda PU (2014) Prospective study of surgical treatment of acromegaly: effects on ghrelin, weight, adiposity, and markers of CV risk. J Clin Endocrinol Metab 99(11):4124\u20134132","journal-title":"J Clin Endocrinol Metab"},{"issue":"3\u20134","key":"1307_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000371818","volume":"103","author":"NC Olarescu","year":"2016","unstructured":"Olarescu NC, Heck A, Godang K, Ueland T, Bollerslev J (2016) The metabolic risk in patients newly diagnosed with acromegaly is related to fat distribution and circulating adipokines and improves after treatment. Neuroendocrinology 103(3\u20134):197\u2013206","journal-title":"Neuroendocrinology"},{"issue":"11","key":"1307_CR16","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1210\/jc.2017-01210","volume":"102","author":"MA Bredella","year":"2017","unstructured":"Bredella MA, Schorr M, Dichtel LE, Gerweck AV, Young BJ, Woodmansee WW, Swearingen B, Miller KK (2017) Body composition and ectopic lipid changes with biochemical control of acromegaly. J Clin Endocrinol Metab 102(11):4218\u20134225","journal-title":"J Clin Endocrinol Metab"},{"key":"1307_CR17","doi-asserted-by":"publisher","first-page":"4125013","DOI":"10.1155\/2018\/4125013","volume":"2018","author":"X Guo","year":"2018","unstructured":"Guo X, Gao L, Shi X, Li H, Wang Q, Wang Z, Chen W, Xing B (2018) Pre- and postoperative body composition and metabolic characteristics in patients with acromegaly: a prospective study. Int J Endocrinol 2018:4125013","journal-title":"Int J Endocrinol"},{"issue":"2","key":"1307_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1530\/EJE-21-0900","volume":"186","author":"P Wolf","year":"2021","unstructured":"Wolf P, Salenave S, Durand E, Young J, Kamenicky P, Chanson P, Maione L (2021) Treatment of acromegaly has substantial effects on body composition: a long-term follow-up study. Eur J Endocrinol 186(2):173\u2013181","journal-title":"Eur J Endocrinol"},{"key":"1307_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.866099","volume":"13","author":"AA Lopes","year":"2022","unstructured":"Lopes AA, Albuquerque L, Fontes M, Rego D, Bandeira F (2022) Body composition in acromegaly according to disease activity - performance of dual X-ray absorptiometry and multifrequency bioelectrical impedance analysis. Front Endocrinol (Lausanne) 13:866099","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1307_CR20","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s11102-015-0657-2","volume":"18","author":"TJ Reid","year":"2015","unstructured":"Reid TJ, Jin Z, Shen W, Reyes-Vidal CM, Fernandez JC, Bruce JN, Kostadinov J, Post KD, Freda PU (2015) IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition. Pituitary 18(6):808\u2013819","journal-title":"Pituitary"},{"issue":"11","key":"1307_CR21","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Society E (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1307_CR22","first-page":"1407","volume":"80","author":"MH Rasmussen","year":"1995","unstructured":"Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J, Skakkebae NE (1995) Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 80(4):1407\u20131415","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1307_CR23","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.1210\/jcem.86.11.8061","volume":"86","author":"H Pijl","year":"2001","unstructured":"Pijl H, Langendonk JG, Burggraaf J, Fr\u00f6lich M, Cohen AF, Veldhuis JD, Meinders AE (2001) Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab 86(11):5509\u20135515","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1307_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1530\/EJE-09-0390","volume":"162","author":"M Tzanela","year":"2010","unstructured":"Tzanela M, Zianni D, Bilariki K, Vezalis A, Gavalas N, Szabo A, Drimala P, Vassiliadi D, Vassilopoulos C (2010) The effect of body mass index on the diagnosis of GH deficiency in patients at risk due to a pituitary insult. Eur J Endocrinol 162(1):29\u201335","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1307_CR25","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1210\/jc.2014-2830","volume":"99","author":"LE Dichtel","year":"2014","unstructured":"Dichtel LE, Yuen KC, Bredella MA, Gerweck AV, Russell BM, Riccio AD, Gurel MH, Sluss PM, Biller BM, Miller KK (2014) Overweight\/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency. J Clin Endocrinol Metab 99(12):4712\u20134719","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1307_CR26","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.4158\/EP161407.DSCR","volume":"22","author":"KC Yuen","year":"2016","unstructured":"Yuen KC, Tritos NA, Samson SL, Hoffman AR, Katznelson L (2016) American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: update on growth hormone stimulation testing and proposed revised cut-point for the glucagon stimulation test in the diagnosis of adult growth hormone deficiency. Endocr Pract 22(10):1235\u20131244","journal-title":"Endocr Pract"},{"issue":"5","key":"1307_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1159\/000508103","volume":"111","author":"V Gasco","year":"2021","unstructured":"Gasco V, Ferrero A, Bisceglia A, Prencipe N, Cambria V, Bioletto F, Ghigo E, Maccario M, Grottoli S (2021) The cut-off limits of growth hormone response to the insulin tolerance test related to body mass index for the diagnosis of adult growth hormone deficiency. Neuroendocrinology 111(5):442\u2013450","journal-title":"Neuroendocrinology"},{"key":"1307_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.111052","volume":"519","author":"M Dixit","year":"2021","unstructured":"Dixit M, Poudel SB, Yakar S (2021) Effects of GH\/IGF axis on bone and cartilage. Mol Cell Endocrinol 519:111052","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"1307_CR29","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1210\/jc.2010-0493","volume":"95","author":"PK Fazeli","year":"2010","unstructured":"Fazeli PK, Lawson EA, Prabhakaran R, Miller KK, Donoho DA, Clemmons DR, Herzog DB, Misra M, Klibanski A (2010) Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 95(11):4889\u20134897","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1307_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11102-008-0104-8","volume":"12","author":"L Katznelson","year":"2009","unstructured":"Katznelson L (2009) Alterations in body composition in acromegaly. Pituitary 12(2):136\u2013142","journal-title":"Pituitary"},{"key":"1307_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.933039","volume":"13","author":"PU Freda","year":"2022","unstructured":"Freda PU (2022) The acromegaly lipodystrophy. Front Endocrinol (Lausanne) 13:933039","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01307-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-023-01307-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01307-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T03:32:35Z","timestamp":1686195155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-023-01307-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1307"],"URL":"https:\/\/doi.org\/10.1007\/s11102-023-01307-6","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"28 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no competing interests related to the topic of this manuscript. PKF is a consultant for Regeneron and Xeris Pharmaceuticals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the University of Pittsburgh institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}